Interplay between Müller cells and microglia aggravates retinal inflammatory response in experimental glaucoma

Area of Science:

• Ophthalmology
• Neuroscience
• Immunology

Background:

• Glaucoma is a leading cause of irreversible blindness, characterized by retinal ganglion cell (RGC) apoptosis.
• RGC death in glaucoma is linked to complex mechanisms involving glial cell interactions.
• The specific contribution of Müller cells and microglia interplay to RGC injury remains unclear.

Purpose of the Study:

• To investigate the interaction between Müller cells and microglia in a mouse model of chronic ocular hypertension (COH).
• To elucidate the underlying mechanisms of glial cell cross-talk contributing to RGC injury in glaucoma.

Main Methods:

• Established a mouse COH experimental glaucoma model.
• Utilized Western blotting, immunofluorescence, q-PCR, co-culture assays, flow cytometry, ELISA, Ca2+ imaging, and TUNEL staining.
• Analyzed Müller cell and microglia activation and their molecular signaling pathways.

Main Results:

• Müller cell activation in COH mice induced microglia activation via the ATP/P2X7 receptor pathway.
• Activated microglia increased pro-inflammatory factors (TNF-α, IL-6) in the retina.
• These factors created a positive feedback loop, up-regulating pro-inflammatory gene expression in Müller cells.

Conclusions:

• Demonstrated a novel interplay between activated Müller cells and microglia exacerbates retinal inflammatory responses in glaucoma.
• This glial cell cross-talk significantly contributes to RGC injury.
• Targeting the Müller cell-microglia interaction presents a potential therapeutic strategy for preventing RGC loss in glaucoma.